LYST Gene Chediak-Higashi Syndrome NGS Genetic DNA Test
Comprehensive Genetic Analysis for Rare Immune Disorder
The LYST Gene Chediak-Higashi Syndrome NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for rare inherited disorders. This sophisticated test utilizes next-generation sequencing technology to examine the LYST (lysosomal trafficking regulator) gene, which plays a critical role in cellular function and immune system regulation. Chediak-Higashi syndrome is an autosomal recessive condition characterized by abnormalities in multiple body systems, making early and accurate diagnosis essential for proper management and treatment planning.
What Does This Test Measure and Detect?
Our advanced NGS genetic test specifically targets the LYST gene to identify pathogenic variants responsible for Chediak-Higashi syndrome. The test detects:
- Point mutations, deletions, and insertions in the LYST gene
- Genetic variants affecting lysosomal membrane trafficking
- Mutations impacting neutrophil function and immune response
- Genetic markers associated with pigment dilution and neurological symptoms
- Inheritance patterns for family genetic counseling
Who Should Consider This Genetic Test?
This comprehensive genetic analysis is recommended for individuals presenting with:
- Recurrent bacterial and viral infections from childhood
- Partial albinism or silver-gray hair coloration
- Increased susceptibility to infections and poor wound healing
- Neurological symptoms including peripheral neuropathy
- Bleeding tendencies and easy bruising
- Family history of similar symptoms or consanguineous parents
- Unexplained developmental delays in children
Significant Benefits of Early Genetic Testing
Undergoing the LYST Gene Chediak-Higashi Syndrome test provides numerous advantages:
- Early and accurate diagnosis enabling timely intervention
- Personalized treatment strategies based on genetic findings
- Improved infection management and prevention protocols
- Informed family planning and genetic counseling opportunities
- Better understanding of disease progression and prognosis
- Access to specialized care and support services
- Potential eligibility for clinical trials and advanced therapies
Understanding Your Test Results
Our comprehensive genetic report provides clear interpretation of your results:
- Positive Result: Indicates the presence of pathogenic LYST gene mutations confirming Chediak-Higashi syndrome diagnosis
- Negative Result: No disease-causing mutations detected in the LYST gene
- Variant of Uncertain Significance: Genetic changes identified requiring further clinical correlation
- Carrier Status: Identification of individuals carrying one copy of the mutated gene
All results are accompanied by detailed explanations and recommendations from our certified genetic counselors to help you understand the implications for your health and family.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures accessible genetic testing services nationwide.
Take Control of Your Genetic Health Today
Don’t let uncertainty about genetic conditions affect your quality of life. Our LYST Gene Chediak-Higashi Syndrome NGS Genetic DNA Test provides the clarity and answers you need for informed healthcare decisions. With a turnaround time of 3-4 weeks and multiple sample collection options including blood, extracted DNA, or one drop of blood on FTA card, getting tested has never been more convenient.
Ready to schedule your genetic test? Call our dedicated genetic counseling team at +1(267) 388-9828 or book your appointment online today. Take the first step toward understanding your genetic health and securing your family’s future.
